Athens Naval Hospital

At Athens Naval Hospital, a major focus is on cardiovascular diseases and related nutritional and metabolic disorders, including atherosclerotic cardiovascular disease, heart failure, atrial fibrillation, hypertension, and dyslipidaemia. These studies are designed to test new ways to reduce serious heart and stroke events, improve symptom control, and lower long-term risk in people with established or high-risk disease.

• Preventing major cardiovascular events in people with atherosclerotic cardiovascular disease or elevated lipoprotein(a)
• Evaluating treatments for heart failure, including forms linked with obesity, inflammation, or kidney impairment
• Studying therapies for atrial fibrillation, hypertension, and mixed lipid disorders

Much of the work at this Cardiology Department is aimed at improving prevention, reducing hospitalizations, and supporting better long-term outcomes for patients with complex cardiovascular risk profiles.

Another prominent area of research at the site is respiratory tract disease, especially asthma, chronic obstructive pulmonary disease, bronchiectasis, and community-acquired pneumonia. The trials in this field are exploring better ways to control inflammation, reduce flare-ups, and improve breathing and lung function in people with chronic or severe lung disease.

• Testing new approaches for severe asthma and asthma with type 2 inflammation
• Assessing treatments for COPD to reduce exacerbations and improve respiratory outcomes
• Studying therapies for bronchiectasis and infection-related complications

These studies reflect a strong interest in both symptom relief and prevention of worsening disease, with some trials also looking at the broader impact on cardiopulmonary health.

The site also conducts extensive research in immune system diseases and autoimmune conditions, including systemic lupus erythematosus, Sjögren’s syndrome, systemic sclerosis, psoriatic arthritis, chronic spontaneous urticaria, and hypogammaglobulinemia linked to immune suppression. The purpose of these trials is to better control disease activity, ease inflammation, and support safer long-term management.

• Improving treatment for systemic lupus erythematosus and Sjögren’s syndrome
• Evaluating therapies for psoriatic arthritis, systemic sclerosis, and urticaria
• Preventing infections in patients with weakened immune function

Research in this area at Athens Naval Hospital is centered on reducing immune-driven symptoms while maintaining safety and quality of life.

Clinical trials in nervous system diseases and psychiatry include studies in acute ischemic stroke, multiple sclerosis, amyotrophic lateral sclerosis, and psychosis associated with Alzheimer’s disease. These projects are focused on improving recovery, slowing progression, and easing difficult neurological and behavioral symptoms.

• Exploring treatments to improve outcomes after acute stroke
• Assessing options for progressive multiple sclerosis and ALS
• Studying therapies for psychosis associated with Alzheimer’s disease

The research combines efforts to support brain health, functional recovery, and symptom control in conditions that can have a major impact on daily living.

Beyond the major disease groups, the site is also involved in studies of eosinophilic esophagitis, community-acquired pneumonia, and other pathological conditions, signs and symptoms tied to inflammation or infection. These trials aim to improve diagnosis, reduce disease burden, and test whether new therapies can better control persistent symptoms.

• Investigating treatment for eosinophilic esophagitis and related swallowing problems
• Studying early intervention strategies for pneumonia to prevent worsening infection
• Evaluating therapies for inflammatory conditions with overlapping systemic effects

This portfolio shows a broad interest in immune-mediated and infection-related illness, with attention to both short-term relief and longer-term disease control.